C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.17
-0.02 (-0.91%)
At close: Sep 26, 2025, 10:59 AM
-0.91% (1D)
Bid | 2.17 |
Market Cap | 154.8M |
Revenue (ttm) | 34.24M |
Net Income (ttm) | -111.58M |
EPS (ttm) | -1.59 |
PE Ratio (ttm) | -1.37 |
Forward PE | -1.38 |
Analyst | Buy |
Dividends | n/a |
Ask | 2.18 |
Volume | 669,570 |
Avg. Volume (20D) | 1,756,841 |
Open | 2.21 |
Previous Close | 2.19 |
Day's Range | 2.13 - 2.25 |
52-Week Range | 1.08 - 7.14 |
Beta | 3.00 |
Ex-Dividend Date | n/a |
About CCCC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CCCC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CCCC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsC4 Therapeutics Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+34.21%
C4 Therapeutics shares are trading higher after St...
Unlock content with
Pro Subscription
1 month ago
+31.63%
C4 Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.